Abstract:OBJECTIVE:To summarize the progress of surgical treatment of hepatocellular carcinoma (HCC) and related basic research at the Liver Cancer Institute of Shanghai Medical University in the recent years, with special reference to recurrence and metastasis.METHODS:Published and unpublished update clinical and experimental data in the above-mentioned areas are summarized.RESULTS:Surgical resection has played an important role in improving prognosis of HCC, the 5-year survival were 63.4% for small HCC resection (n = 806), 39.6% for large HCC resection (n = 1061), 64.7% for cytoreduction (using hepatic artery cannulation and ligation) and sequential resection of initially unresectable HCC (n = 93), 56.0% for cytoreduction using transcatheter arterial chemoembolization (TACE) and followed by resection (n = 65), and 22.4% for hepatic resection with removal of tumor thrombi in portal vein (n = 103). Unfortunately, the 5-year recurrent rate after curative resection of HCC was up to 61.5%, which was mainly a result of intrahepatic "metastasis" and multicentric origin of HCC. Clinically, re-resection of subclinical recurrence yielded 56% of 5-year survival (n = 202); prevention of recurrence by transcatheter arterial chemoembolization (TACE) + Interferon, or LAK/IL-2 therapy have decreased 3-year recurrent rate from 33% to 11%-18%. In experimental aspect, metastatic human HCC model in nude mice (LCI-D20) and HCC cell line with metastatic potential (MHCC97) have been established; studies on HCC invasiveness in the molecular level revealed similar results that reported in other solid cancers, and small HCC showed slightly better biological characteristics as compared with large HCC; microvessel density (MVD) that reflecting angiogenesis adversely correlated with 5-year survival of small HCC; experimental interventions using antisense H-ras, bispecific antibody, BB94, as well as anti-angiogenic agents (TNP470, suramin, CAI, heparin, antisense VEGF, etc.) have been demonstrated to inhibit tumor growth and lung metastasis in nude mice model.CONCLUSIONS:Recurrence and metastasis are the major obstacle to further improve prognosis of HCC, studies should be conducted both in clinical and experimental aspects, "HCC invasiveness" will be the major target to be studied, particularly in the molecular level, and anti-angiogenesis will be one of the important approach.

Important Issues of Cancer Metastasis

New Perspectives on Recurrence and Metastasis of Liver Cancer

A Decade’s Studies on Metastasis of Hepatocellular Carcinoma

Clinical and Experimental Studies on Recurrence and Metastasis of Hepatocellular Carcinoma-Progress and Prospect

Cancer metastases: challenges and opportunities

Surgical Treatment of Hepatocellular Carcinoma and Related Basic Research with Special Reference to Recurrence and Metastasis

Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives

Metastasis and Recurrence after Surgical Resection of Hepatocellular Carcinoma: Recent Progress in Clinical and Related Basic Aspects

Tumor-Associated Neutrophils: an Emerging Player in the Immune Microenvironment of Hepatocellular Carcinoma

Studies on Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma

Cancer Metastasis, A Clinical Dilemma For Therapeutics

Reasons for Cancer Metastasis: A Holistic Perspective.

The role of liver cancer stem cells in hepatocellular carcinoma metastasis

Multi-stage mechanisms of tumor metastasis and therapeutic strategies

Advances in mechanism and treatment strategy of cancer.

Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives

Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination

Personal Opinion on Improving the Outcome of Treatment for Liver Cancer

Recent Advances in the Studies of Hepatocellular Carcinoma

Analysis of the Metastatic Mechanism and Progress in the Treatment of Breast Cancer Liver Metastasis: a Narrative Review

Fighting Against Cancer by Integrative Medicine